- Home
- BWMN vs ACIU Comparison
BWMN vs ACIU Comparison
Compare BWMN & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWMN
- ACIU
- Stock Information
- Founded
- BWMN 1995
- ACIU 2003
- Country
- BWMN United States
- ACIU Switzerland
- Employees
- BWMN N/A
- ACIU N/A
- Industry
- BWMN Military/Government/Technical
- ACIU Biotechnology: Pharmaceutical Preparations
- Sector
- BWMN Consumer Discretionary
- ACIU Health Care
- Exchange
- BWMN Nasdaq
- ACIU Nasdaq
- Market Cap
- BWMN 372.1M
- ACIU 305.7M
- IPO Year
- BWMN 2021
- ACIU 2016
- Fundamental
- Price
- BWMN $27.05
- ACIU $3.27
- Analyst Decision
- BWMN Strong Buy
- ACIU Strong Buy
- Analyst Count
- BWMN 5
- ACIU 2
- Target Price
- BWMN $39.70
- ACIU $12.00
- AVG Volume (30 Days)
- BWMN 92.4K
- ACIU 131.4K
- Earning Date
- BWMN 11-06-2024
- ACIU 11-05-2024
- Dividend Yield
- BWMN N/A
- ACIU N/A
- EPS Growth
- BWMN N/A
- ACIU N/A
- EPS
- BWMN N/A
- ACIU N/A
- Revenue
- BWMN $406,307,000.00
- ACIU $48,505,404.00
- Revenue This Year
- BWMN $22.70
- ACIU N/A
- Revenue Next Year
- BWMN $15.00
- ACIU $938.44
- P/E Ratio
- BWMN N/A
- ACIU N/A
- Revenue Growth
- BWMN 23.54
- ACIU 4097200.00
- 52 Week Low
- BWMN $19.93
- ACIU $2.25
- 52 Week High
- BWMN $42.90
- ACIU $5.14
- Technical
- Relative Strength Index (RSI)
- BWMN 70.94
- ACIU 54.88
- Support Level
- BWMN $24.50
- ACIU $3.11
- Resistance Level
- BWMN $26.35
- ACIU $3.41
- Average True Range (ATR)
- BWMN 1.15
- ACIU 0.23
- MACD
- BWMN 0.36
- ACIU 0.03
- Stochastic Oscillator
- BWMN 97.53
- ACIU 46.72
About BWMN Bowman Consulting Group Ltd.
Bowman Consulting Group Ltd is a professional services firm delivering engineering solutions to customers who own, develop, and maintain the built environment. It provides planning, engineering, construction management, commissioning, environmental consulting, geospatial, survey, land procurement, and other technical services to customers operating in a diverse set of end markets. Its services include Civil & Site Engineering, Transportation Engineering, MEP Engineering, Commissioning & Energy Efficiency, Energy Services, Water/Wastewater, Fire Protection, Construction Management, Survey/Geospatial, Environmental Consulting, Structural Engineering, Land Procurement & Right-of-Way, Landscape, and Architecture/Planning.
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.